)

Journey Medical Corp (DERM) investor relations material
Journey Medical Corp Emerging Growth Conference 85 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and market position
Commercial-stage pharmaceutical company focused on dermatology, with a strong sales and marketing model and a portfolio of FDA-approved products.
Public since November 2021, with a robust balance sheet and recent addition to the Russell 2000 index.
Operates in a $6 billion dermatology market, targeting rosacea, hyperhidrosis, and acne.
Core business generated $55 million in net revenue in 2024, excluding new product launches.
Sales organization covers 80% of top 50 US MSAs, reaching 70% of dermatology prescriptions in target disease states.
Product portfolio and launch highlights
Key products include QBREXZA (hyperhidrosis), AMZEEQ and ZILXI (acne and rosacea), and Accutane, with Imrozi as the new growth driver.
Imrozi, an oral minocycline for rosacea, approved in November 2024 and launched in April 2025.
Imrozi demonstrated superior efficacy to Oracea and placebo in phase 3 trials, with rapid onset and strong safety profile.
Over 12,000 prescriptions and 1,800 unique prescribers achieved within four months of launch.
Market access rapidly expanding, with over 100 million covered lives and growing payer acceptance.
Financial performance and growth strategy
Q2 2025 revenue at $15 million, annual run rate near $60 million, approaching breakeven.
Imrozi expected to drive profitability and sustainable revenue growth, with fixed sales infrastructure enabling earnings leverage.
Out-licensing deals, such as QBREXZA to Maruho and Amzeeq to a Chinese partner, provide non-dilutive capital and royalties.
Business development includes adding new FDA-approved products every 18 months and exploring further out-licensing opportunities.
Corporate priorities: flawless Imrozi launch, expanding payer coverage, achieving EBITDA positive, and pursuing additional product acquisitions.
Next Journey Medical Corp earnings date

Next Journey Medical Corp earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage